Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros









Base de dados
Intervalo de ano de publicação
1.
The Cost Effectiveness Analysis Of The Oral Anti-Viral Treatments Alternatives For The Chronic Hepatitis B In Turkey.
Kockaya, G; Kose, A; Dalgic, C; Yenilmez, F B; Ozdemir, O; Kucuksayrac, E; Tayfun, K.
Value Health ; 17(7): A367, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27200770
2.
Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey.
Safak, Yilmaz E; Kockaya, G; Yenilmez, F B; Saylan, M; Tatar, M; Hilal, Vural E; Vural, I M; Akbulat, A; Gursoz, H; Artiran, G; Kerman, S.
Value Health ; 17(7): A408, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27200995
3.
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey.
Kockaya, G; Yenilmez, F B; Saylan, M; Safak, Yilmaz E; Tatar, M; Hilal, Vural E; Vural, I M; Akbulat, A; Gursoz, H; Artiran, G; Kerman, S.
Value Health ; 17(7): A410-1, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201004
4.
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey.
Hilal, Vural E; Kockaya, G; Yenilmez, F B; Saylan, M; Safak, Yilmaz E; Tatar, M; Vural, I M; Akbulat, A; Gursoz, H; Artiran, G; Kerman, S.
Value Health ; 17(7): A410, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201006
5.
Impact of Health Policy Changes on the Cost Sales of 5 Top Selling ATC1 Phramaceutical Groups in Turkey.
Yenilmez, F B; Kockaya, G; Saylan, M; Safak, Yilmaz E; Tatar, M; Hilal, Vural E; Vural, I M; Akbulat, A; Gursoz, H; Artiran, G; Kerman, S.
Value Health ; 17(7): A410, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201009
6.
Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey.
Saylan, M; Safak, Yilmaz E; Yenilmez, F B; Kockaya, G; Tatar, M; Hilal, Vural E; Vural, I M; Akbulat, A; Gursoz, H; Artiran, G; Kerman, S.
Value Health ; 17(7): A411, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201012
7.
The Trend of the Prices Of New Marketed Drugs in Turkey.
Yenilmez, F B; Kockaya, G.
Value Health ; 17(7): A420, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201066
8.
Economic Impact of Clinical Researches to the Research Centers and Reimbursement Systems in Turkey.
Kockaya, G; Daylan, Kockaya P; Demir, M; Uresin, A Y.
Value Health ; 17(7): A421, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201071
9.
Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue: A Comparison In Usa, Canada, Japan and Australia.
Yenilmez, F B; Tuna, E; Atikeler, K; Kockaya, G; Tatar, M.
Value Health ; 17(7): A423, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201083
10.
Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue for Turkey.
Kockaya, G; Tuna, E; Yenilmez, F B; Atikeler, K; Tatar, M.
Value Health ; 17(7): A424-5, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201085
11.
Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue: A Comparison in France, Germany, Italy, Spain, United Kingdom.
Tuna, E; Yenilmez, F B; Atikeler, K; Kockaya, G; Tatar, M.
Value Health ; 17(7): A424, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201087
12.
Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue: A Comparison In Argentina, Brazil And Mexico.
Atikeler, K; Tuna, E; Yenilmez, F B; Tatar, M; Kockaya, G.
Value Health ; 17(7): A425, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201093
13.
Incidence Of Unlicensed And Off-Label Prescription In Urologic Cancers Therapy In Turkey: Assessment Of Legislative And Regulatory Policy.
Tanyeri, M H; Kockaya, G; Tanyeri, P; Yenilmez, F B; Buyukokuroglu, M E; Vural, I M; Akbulat, A; Artiran, G; Kerman, S.
Value Health ; 17(7): A472, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27201355
14.
A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment.
Malhan, S; Kockaya, G; Elbir Zengin, T; Dalgic, C; Yenilmez, F B; Cerci, P; Oksuz, E; Tayfun, K; Unal, S.
Value Health ; 17(7): A677, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27202495
15.
The Cost-Effectiveness Analysis for Hiv Treatment Alternatives in Turkey.
Kockaya, G; Yenilmez, F B; Elbir Zengin, T; Dalgic, C; Malhan, S; Cerci, P; Oksuz, E; Tayfun, K; Unal, S.
Value Health ; 17(7): A678, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27202504
ENVIAR RESULTADO:
Email
Exportar
Imprimir
RSS
XML
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA